Brief: Suven Life Sciences Gets Product Patents In New Zealand, Norway
22/05/2018 06:14
May 22 (Reuters) - Suven Life Sciences Ltd SUVP.NS :
* SAYS CO SECURES PRODUCT PATENTS IN NEW ZEALAND AND NORWAY
* SUVEN LIFE SCIENCES SAYS PATENTS CORRESPONDING TO NEW
CHEMICAL
ENTITIES FOR TREATMENT OF DISORDERS ASSOCIATED WITH
NEURODEGENERATIVE DISEASES
* SAYS PATENTS ARE VALID THROUGH 2034 AND 2027
Source text - http://bit.ly/2s8vnN9
Further company coverage: SUVP.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Suven Life Sciences
See all newsBrief: Suven Life Sciences Completes Phase-1 Study Of SUVN-I6107, Advances To Phase-2
Brief: Suven Life Sciences Reports Positive DSMB Safety Review For Phase-3 Masupirdine Study
Brief: Suven Life Sciences Records 100% Patient Enrolment Milestone In Phase-2B Clinical Trial Of Ropanicant
Brief: Suven Life Sciences Says First Patient Randomized In Phase-2B Clinical Trial Of Ropanicant
Brief: Suven Life Sciences March-Quarter Consol Net Loss 439.4 Million Rupees